Sethuraman Natarajan
Officer at TRDA
- Sold, on record
- $1.9M
- Dollars the filings state
- Form 4 sales
- 10
- Latest May 4, 2026
- Form 144 notices
- 6
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TRDAEntrada Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice TRDANoticeOct 16, 2024 2024
Filed to sell 20,057 shares ($352k)
Sethuraman Natarajan, Officer
10b5-1 plan5.1x usual sizeFiling
- 2 Form 4 sale TRDARoutineOct 16, 2024 same day
Sold 600 shares at $18.00 ($11k)
Sethuraman Natarajan, President, Research & Develop.
10b5-1 planSold 0.3% of holdings ($3.3M position)183,216 shares left0.2x usual sizeFollows a Form 144Filing
- 3 Form 4 sale TRDAUnusualNov 6, 2024 +21 days
Sold 18,219 shares at $18.62 ($339k)
Sethuraman Natarajan, President, Research & Develop.
10b5-1 planSold 9.9% of holdings ($3.4M position)164,997 shares left5.1x usual sizeFollows a Form 144Filing
- 4 Form 144 notice TRDANoticeNov 11, 2024 +5 days
Filed to sell 18,762 shares ($372k)
Sethuraman Natarajan, Officer
10b5-1 plan4.7x usual sizeFiling
- 5 Form 4 sale TRDARoutineNov 13, 2024 +2 days
Sold 4,109 shares at $20.03 ($82k)
Sethuraman Natarajan, President, Research & Develop.
10b5-1 planSold 2.5% of holdings ($3.3M position)160,888 shares left1x usual sizeFollows a Form 144Filing
- 6 Form 4 sale TRDAUnusualDec 3, 2024 +20 days
Sold 15,891 shares at $20.18 ($321k)
Sethuraman Natarajan, President, Research & Develop.
10b5-1 planSold 9.9% of holdings ($3.2M position)144,997 shares left3.9x usual sizeFollows a Form 144Filing
- 7 Form 144 notice TRDANoticeMay 4, 2026 +517 days
Filed to sell 25,907 shares ($376k)
Sethuraman Natarajan, Officer
10b5-1 plan6.3x usual sizeFiling
- 8 Form 4 sale TRDAUnusualMay 4, 2026 same day
Sold 25,907 shares at $15.39 ($399k)
Sethuraman Natarajan, President, Research & Develop.
10b5-1 planSold 10.7% of holdings ($3.7M position)216,317 shares left6.3x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (16)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | May 4, 2026 | TRDA | President, Research & Develop. | Form 4 sale | 25,907 | $399k | 10.7% | Unusual | SEC |
| May 4, 2026 | May 4, 2026 | TRDA | Officer | Form 144 notice | 25,907 | $376k | Notice | SEC | |
| Dec 3, 2024 | Dec 3, 2024 | TRDA | President, Research & Develop. | Form 4 sale | 15,891 | $321k | 9.9% | Unusual | SEC |
| Nov 13, 2024 | Nov 13, 2024 | TRDA | President, Research & Develop. | Form 4 sale | 4,109 | $82k | 2.5% | Routine | SEC |
| Nov 11, 2024 | Nov 12, 2024 | TRDA | Officer | Form 144 notice | 18,762 | $372k | Notice | SEC | |
| Nov 6, 2024 | Nov 6, 2024 | TRDA | President, Research & Develop. | Form 4 sale | 18,219 | $339k | 9.9% | Unusual | SEC |
| Oct 16, 2024 | Oct 18, 2024 | TRDA | President, Research & Develop. | Form 4 sale | 600 | $11k | 0.3% | Routine | SEC |
| Oct 16, 2024 | Oct 16, 2024 | TRDA | Officer | Form 144 notice | 20,057 | $352k | Notice | SEC | |
| Sep 9, 2024 | Sep 10, 2024 | TRDA | Chief Scientific Officer | Form 4 sale | 3,242 | $49k | 1.7% | Routine | SEC |
| Jul 15, 2024 | Jul 16, 2024 | TRDA | Chief Scientific Officer | Form 4 sale | 1,238 | $22k | 0.7% | Routine | SEC |
| Jul 12, 2024 | Jul 12, 2024 | TRDA | Officer | Form 144 notice | 20,057 | $348k | Notice | SEC | |
| May 20, 2024 | May 20, 2024 | TRDA | Chief Scientific Officer | Form 4 sale | 18,980 | $288k | 9.1% | Routine | SEC |
| May 16, 2024 | May 16, 2024 | TRDA | Officer | Form 144 notice | 18,980 | $275k | Notice | SEC | |
| Jul 11, 2023 | Jul 12, 2023 | TRDA | Chief Scientific Officer | Form 4 sale | 17,878 | $322k | 10.4% | Routine | SEC |
| Apr 17, 2023 | Apr 19, 2023 | TRDA | Chief Scientific Officer | Form 4 sale | 3,961 | $71k | 2.3% | Routine | SEC |
| Apr 17, 2023 | Apr 17, 2023 | TRDA | Officer | Form 144 notice | 21,839 | $377k | Notice | SEC |